DAVID KIM, MD, partner
David joined Pinnacle Ventures in 2007 to lead the firm's healthcare investment efforts. Prior to Pinnacle, David worked at MPM Capital, where he was involved with successful investments in multiple biotech and medical device companies. At MPM, he also worked closely with several portfolio companies including HemoSense (acquired by Inverness Medical), CHF Solutions (acquired by Gambro), IntraLuminal and Innovative Spinal Technologies. His other experiences in financial services include positions as a Senior Equity Analyst at Pacific Growth Equities covering medical devices, a Senior Equities Analysts for Firsthand Capital Management evaluating biotech and device companies, and a Medical Device Research Associate at Banc of America Securities. David also worked as a business development intern at Compass, a business development unit of Guidant Corporation. Prior to transitioning to the investment arena, David served as the Director of Urgent Care and Assistant Chief of Internal Medicine at Kaiser South San Francisco.
David finished his internal medicine residency at Harbor-UCLA Medical Center and practiced clinical medicine as a board certified internist. He received his M.D. from the Johns Hopkins University School of Medicine and his MBA from Stanford Graduate School of Business. He also graduated from Pomona College with a BA in biology.
David’s past Pinnacle healthcare efforts include Cameron Health (acquired by Boston Scientific), Lutonix (acquired by CR Bard), and Calistoga (acquired by Gilead).
Cameron Health (BSC)